Aimed Alliance and HR.com have launched a new webpage highlighting our 2024 survey findings; infographic, and webinar for employers and…
The Oregon Prescription Drug Affordability Board is currently reviewing the affordability of 27 selected medications and has requested feedback from…
On April 22, 2025, Aimed Alliance released a new resource titled “Tariffs 101: How Tariffs Could Impact Patients.” Since the start…
On October 7, 2024, the U.S. Department of Health and Human Services (HHS) issued a Request for Information (RFI) to…
On December 4, 2024, Aimed Alliance hosted a webinar on HR.com titled “Supporting Women in Midlife: Survey Insights on Workplace…
On November 14, 2024, Aimed Alliance and the Alliance for Patient Access (AfPA) hosted a webinar on HR.com titled “Copay…
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to prescribe controlled substances without an…
The Coalition for Health AI (CHAI), a group of stakeholders that collaborate to drive the development, evaluation, and appropriate use…
On November 8, 2024, Aimed Alliance submitted feedback to the Maryland Prescription Drug Affordability Board regarding its updated rules for…
Currently, Medicare coverage for anti-obesity medications is limited to indications for diabetes and cardiovascular disease. Policymakers, however, have proposed expanding…